Americans Favor Psilocybin For Mental Health Treatment, Study Finds
A new study published in AJOB Neuroscience reveals that most Americans are supportive of psilocybin use, a psychedelic compound derived from “magic mushrooms,” in supervised, licensed settings. As PsyPost reported, this approval, spanning across political lines, underscores public openness to the controlled use of psilocybin for mental health treatment and general well-being, despite remaining concerns for policy caution.
Psilocybin, a Schedule 1 drug in the U.S., has long been classified as having a high potential for abuse with no accepted medical use. However, recent clinical studies suggest it may help alleviate symptoms of conditions such as treatment-resistant depression when administered under professional supervision. Unlike many medications, psilocybin is considered non-addictive, and studies have found it may also enhance overall well-being in healthy individuals.
This research aimed to explore public perceptions of psilocybin amid recent legislative progress, such as Oregon’s law